Publication | Closed Access

Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents

Medicinal ChemistryCell Cycle AnalysisMedicineAzole-hydrazone DerivativesPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyMolecular Docking StudyDrug Discovery